Mexican Billionaire Slim Backs Biotech Firm Focused On Cancer and Kidney Disease Treatments

Atara Biotherapeutics Inc., a company in which Mexican billionaire Carlos Slim owns shares, filed for an initial public offering to expand kidney disease research - an illness that runs in the Slim family.